GlassScriptPhysician profile
Stavros Stavropoulos
NPI 1679657019
$101,973.23
in general payments reported to CMS, 2019-2025
20 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $2,783 · 2021: $6,982 · 2022: $9,186 · 2023: $19K · 2024: $16K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $5,172 · Travel and Lodging: $4,726 · Education: $3,690 · Honoraria: $2,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,407.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,000.00 |
| Food and Beverage | $5,171.86 |
| Travel and Lodging | $4,726.04 |
| Education | $3,690.00 |
| Honoraria | $2,360.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $37,794.78 | 2019-2025 | General - Therapies, Wallflex Duodenal, Overstitch Endoscopic Suturing System |
| Lumendi LLC | $18,834.99 | 2019-2024 | Dilumen Endolumenal Interventional Platform, Dilumen C1, 130 Cm, Dilumen C1, 103 Cm |
| Olympus America INC. | $14,150.19 | 2019-2025 | Single Use Electrosurgical Knife Kd-655, Single Use Repositionable Clip, Endoclot Sis |
| Olympus Corporation of The Americas | $11,422.88 | 2021-2025 | Hanarostent Biliary (Nnn), Single Use Electrosurgical Knife Kd-655 |
| Olympus Medical Systems Corporation | $6,147.89 | 2024-2025 | Single Use Electrosurgical Knife Kd-655 |
| Erbe USA INC | $4,678.07 | 2021-2025 | Hybridknife Ejet 2, Hk Flex, Vio 3 Ejet 2 |
| Erbe Elektromedizin Gmbh | $3,860.00 | 2021-2023 | |
| Olympus Corporation | $3,075.00 | 2019 | |
| Apollo Endosurgery US INC | $355.33 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Fujifilm Healthcare Americas Corporation | $306.77 | 2022-2023 | Fujifilm |
| Covidien LP | $245.56 | 2019 | |
| Conmed Corporation | $207.94 | 2019-2024 | Conmed Biliary |
| Merit Medical Systems INC | $198.75 | 2025 | Esophyx |
| Micro-Tech Endoscopy USA, INC. | $169.50 | 2019 | |
| Medtronic, INC. | $152.41 | 2023 | Endoflip |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $124.93 | 2024 | |
| Endogastric Solutions, INC | $115.97 | 2023-2024 | Esophyx |
| 3-D Matrix, INC. | $65.57 | 2024 | |
| Qol Medical, LLC | $44.07 | 2025 | Sucraid |
| Novo Nordisk INC | $22.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stavros Stavropoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.